EVALUATION Of CLINICAL AND ECONOMIC EFF ICIENCY Of METHODS MEASURING FRACTIONAL FLOW RESERVE IN THE TREATMENT OF CORONARY HEART DISEASE PATIENS
https://doi.org/10.17802/2306-1278-2016-4-33-38
Abstract
Purpose. Examine the clinical and cost-effectiveness of the use of methods of measurement of fractional flow reserve in the treatment of coronary heart disease patients with multivessel coronary.
Materials and Methods. The study included 62 patients with coronary heart disease and multivessel coronary disease who underwent multi-stage endovascular revascularization.
Results. Conducting clinical and economic analysis showed that the use of additional methods of measurement of fractional flow reserve in patients with multivessel coronary disease increases the cost of percutaneous coronary interventions during the first phase of myocardial revascularization. But at the same time, it reduces the cost of treatment of the patient in general, reducing the «cost of disease.» This is achieved by reducing the need for patient readmission rates for the second phase of myocardial revascularization.
About the Authors
M. A. SINKOVRussian Federation
Address: 6, Sosnoviy blvd., Kemerovo, 650002, Russian Federation Tel.: +7 (3842) 64-36-80
K. M. VAKKOSOV
Russian Federation
A. A. SHILOV
Russian Federation
O. Yu. BOGDANOV
Russian Federation
E. A. POGORELOV
Russian Federation
A. A. SINKOV
Russian Federation
V. I. GANYUKOV
Russian Federation
O. L. BARBARASH
Russian Federation
References
1. О совершенствовании деятельности врачей клинических фармакологов: Приказ Минздрава РФ от 22.10.2003 № 494. URL: http://lawru.info/legal2/se14/pravo14864/index.htm. O sovershenstvovanii dejatel’nosti vrachej klinicheskih farmakologov: Prikaz Minzdrava RF ot 22.10.2003 № 494. URL: http://lawru.info/legal2/se14/pravo14864/index.htm.
2. Маркун Т. А. Клинико-экономический анализ. URL: http://bono-esse.ru/blizzard/DM/ebm_y4.html. Markun T. A. Kliniko-jekonomicheskij analiz. URL: http://bono-esse.ru/blizzard/DM/ebm_y4.html.
3. Пархоменко Е. Фармакоэкономика для фармацевтов. Фармацевтическое обозрение. 2003; 7–8. URL: http://www.worklib.ru/laws/ml02/pages/10016396.php. Parhomenko E. Farmakojekonomika dlja farmacevtov //Farmacevticheskoe obozrenie. 2003; 7–8. URL: http://www.worklib.ru/laws/ml02/pages/10016396.php.
4. Pijls N. H., De Bruyne B., Peels K. et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenosis. N. Engl. J. Med. 1996; 334: 1703–1708.
5. Pijls N. H. J., Van Gelder B., Van der Voort P. et al. Fractional flow reserve: A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995; 92: 3183–3193.
6. De Bruyne B., Pijls N. H. J., Barbato E. et al. Intracoronary and intravenous adenosine 5′- triphosphate, papaverine, and contrast medium to assess factional flow reserve in humans. Circulation. 2003; 107–187.
Review
For citations:
SINKOV M.A., VAKKOSOV K.M., SHILOV A.A., BOGDANOV O.Yu., POGORELOV E.A., SINKOV A.A., GANYUKOV V.I., BARBARASH O.L. EVALUATION Of CLINICAL AND ECONOMIC EFF ICIENCY Of METHODS MEASURING FRACTIONAL FLOW RESERVE IN THE TREATMENT OF CORONARY HEART DISEASE PATIENS. Complex Issues of Cardiovascular Diseases. 2016;(4):33-38. (In Russ.) https://doi.org/10.17802/2306-1278-2016-4-33-38